(3R,4S)-3-(6-chloro-3-pyridyl)-7-azabicyclo[2.2.1]heptane (BioDeep_00001036094)

   


代谢物信息卡片


(3R,4S)-3-(6-chloro-3-pyridyl)-7-azabicyclo[2.2.1]heptane

化学式: C11H13ClN2 (208.0767208)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: C1CC2C(CC1N2)C3=CN=C(C=C3)Cl
InChI: InChI=1S/C11H13ClN2/c12-11-4-1-7(6-13-11)9-5-8-2-3-10(9)14-8/h1,4,6,8-10,14H,2-3,5H2/t8?,9-,10+/m1/s1

描述信息

D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018679 - Cholinergic Agonists
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents
D002491 - Central Nervous System Agents > D000700 - Analgesics

同义名列表

1 个代谢物同义名

(3R,4S)-3-(6-chloro-3-pyridyl)-7-azabicyclo[2.2.1]heptane



数据库引用编号

2 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Yohei Shimizu, Takahiro Shimizu, Suo Zou, Hideaki Ono, Yurika Hata, Masaki Yamamoto, Takaaki Aratake, Shogo Shimizu, Youichirou Higashi, Takashi Karashima, Motoaki Saito. Stimulation of brain α7-nicotinic acetylcholine receptors suppresses the rat micturition through brain GABAergic receptors. Biochemical and biophysical research communications. 2021 04; 548(?):84-90. doi: 10.1016/j.bbrc.2021.02.051. [PMID: 33636639]
  • Bahare Salehi, Simona Sestito, Simona Rapposelli, Gregorio Peron, Daniela Calina, Mehdi Sharifi-Rad, Farukh Sharopov, Natália Martins, Javad Sharifi-Rad. Epibatidine: A Promising Natural Alkaloid in Health. Biomolecules. 2018 12; 9(1):. doi: 10.3390/biom9010006. [PMID: 30583611]
  • Youichirou Higashi, Takahiro Shimizu, Masaki Yamamoto, Kenjiro Tanaka, Toshio Yawata, Shogo Shimizu, Suo Zou, Tetsuya Ueba, Kazunari Yuri, Motoaki Saito. Stimulation of brain nicotinic acetylcholine receptors activates adrenomedullary outflow via brain inducible NO synthase-mediated S-nitrosylation. British journal of pharmacology. 2018 10; 175(19):3758-3772. doi: 10.1111/bph.14445. [PMID: 30007012]
  • Philip Hunter. Do not poison thyself: Mechanisms to avoid self-toxicity could inspire novel compounds and pathways for synthetic biology and applications for agriculture. EMBO reports. 2018 09; 19(9):. doi: 10.15252/embr.201846756. [PMID: 30150322]
  • Richard W Fitch, Barry B Snider, Quan Zhou, Bruce M Foxman, Anshul A Pandya, Jerrel L Yakel, Thao T Olson, Nour Al-Muhtasib, Yingxian Xiao, Kevin D Welch, Kip E Panter. Absolute Configuration and Pharmacology of the Poison Frog Alkaloid Phantasmidine. Journal of natural products. 2018 04; 81(4):1029-1035. doi: 10.1021/acs.jnatprod.8b00062. [PMID: 29671588]
  • B T Green, S T Lee, J W Keele, K D Welch, D Cook, J A Pfister, W R Kem. Complete inhibition of fetal movement in the day 40 pregnant goat model by the piperidine alkaloid anabasine but not related alkaloids. Toxicon : official journal of the International Society on Toxinology. 2018 Mar; 144(?):61-67. doi: 10.1016/j.toxicon.2018.02.007. [PMID: 29452148]
  • Yosuke Shiraishi, Tadashi Ogawa, Takayoshi Suzuki, Masae Iwai, Maiko Kusano, Kei Zaitsu, Fumio Kondo, Akira Ishii, Hiroshi Seno. Simultaneous quantification of batrachotoxin and epibatidine in plasma by ultra-performance liquid chromatography/tandem mass spectrometry. Legal medicine (Tokyo, Japan). 2017 Mar; 25(?):1-5. doi: 10.1016/j.legalmed.2016.12.008. [PMID: 28457503]
  • Benedict T Green, Stephen T Lee, Kevin D Welch, Daniel Cook, William R Kem. Activation and Desensitization of Peripheral Muscle and Neuronal Nicotinic Acetylcholine Receptors by Selected, Naturally-Occurring Pyridine Alkaloids. Toxins. 2016 07; 8(7):. doi: 10.3390/toxins8070204. [PMID: 27384586]
  • Paula L Vieira-Brock, Lisa M McFadden, Shannon M Nielsen, Jonathan D Ellis, Elliot T Walters, Kristen A Stout, J Michael McIntosh, Diana G Wilkins, Glen R Hanson, Annette E Fleckenstein. Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits. The Journal of pharmacology and experimental therapeutics. 2015 Dec; 355(3):463-72. doi: 10.1124/jpet.114.221945. [PMID: 26391161]
  • Takahiro Shimizu, Kenjiro Tanaka, Shogo Shimizu, Youichirou Higashi, Toshio Yawata, Kumiko Nakamura, Keisuke Taniuchi, Tetsuya Ueba, Kazunari Yuri, Motoaki Saito. Possible inhibitory role of endogenous 2-arachidonoylglycerol as an endocannabinoid in (±)-epibatidine-induced activation of central adrenomedullary outflow in the rat. Neuropharmacology. 2015 Aug; 95(?):278-89. doi: 10.1016/j.neuropharm.2015.03.034. [PMID: 25882827]
  • Michael J Marks, Sharon R Grady, Outi Salminen, Miranda A Paley, Charles R Wageman, J Michael McIntosh, Paul Whiteaker. α6β2*-subtype nicotinic acetylcholine receptors are more sensitive than α4β2*-subtype receptors to regulation by chronic nicotine administration. Journal of neurochemistry. 2014 Jul; 130(2):185-98. doi: 10.1111/jnc.12721. [PMID: 24661093]
  • Andreas H Rasmussen, Dorte Strøbæk, Tino Dyhring, Marianne L Jensen, Dan Peters, Morten Grunnet, Daniel B Timmermann, Philip K Ahring. Biophysical and pharmacological characterization of α6-containing nicotinic acetylcholine receptors expressed in HEK293 cells. Brain research. 2014 Jan; 1542(?):1-11. doi: 10.1016/j.brainres.2013.10.024. [PMID: 24157862]
  • Athanasios Metaxas, Ream Al-Hasani, Pamela Farshim, Kristina Tubby, Amy Berwick, Catherine Ledent, Susanna Hourani, Ian Kitchen, Alexis Bailey. Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain. Neuropharmacology. 2013 Aug; 71(?):228-36. doi: 10.1016/j.neuropharm.2013.03.023. [PMID: 23583933]
  • David Pubill, Sara Garcia-Ratés, Jordi Camarasa, Elena Escubedo. 3,4-Methylenedioxy-methamphetamine induces in vivo regional up-regulation of central nicotinic receptors in rats and potentiates the regulatory effects of nicotine on these receptors. Neurotoxicology. 2013 Mar; 35(?):41-9. doi: 10.1016/j.neuro.2012.11.008. [PMID: 23261423]
  • Takahiro Shimizu, Kenjiro Tanaka, Kumiko Nakamura, Keisuke Taniuchi, Kunihiko Yokotani. Brain phospholipase C, diacylglycerol lipase and monoacylglycerol lipase are involved in (±)-epibatidine-induced activation of central adrenomedullary outflow in rats. European journal of pharmacology. 2012 Sep; 691(1-3):93-102. doi: 10.1016/j.ejphar.2012.07.017. [PMID: 22796670]
  • Cristian A Zambrano, Rakel M Salamander, Allan C Collins, Sharon R Grady, Michael J Marks. Regulation of the distribution and function of [(125)I]epibatidine binding sites by chronic nicotine in mouse embryonic neuronal cultures. The Journal of pharmacology and experimental therapeutics. 2012 Aug; 342(2):245-54. doi: 10.1124/jpet.112.192542. [PMID: 22532626]
  • Tresa M McGranahan, Natalie E Patzlaff, Sharon R Grady, Stephen F Heinemann, T K Booker. α4β2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2011 Jul; 31(30):10891-902. doi: 10.1523/jneurosci.0937-11.2011. [PMID: 21795541]
  • Benedict T Green, Kevin D Welch, Daniel Cook, Dale R Gardner. Potentiation of the actions of acetylcholine, epibatidine, and nicotine by methyllycaconitine at fetal muscle-type nicotinic acetylcholine receptors. European journal of pharmacology. 2011 Jul; 662(1-3):15-21. doi: 10.1016/j.ejphar.2011.04.053. [PMID: 21554871]
  • Brandon J Henderson, Ryan E Pavlovicz, Jerad D Allen, Tatiana F González-Cestari, Crina M Orac, Andrew B Bonnell, Michael X Zhu, R Thomas Boyd, Chenglong Li, Stephen C Bergmeier, Dennis B McKay. Negative allosteric modulators that target human alpha4beta2 neuronal nicotinic receptors. The Journal of pharmacology and experimental therapeutics. 2010 Sep; 334(3):761-74. doi: 10.1124/jpet.110.168211. [PMID: 20551292]
  • Vladimir Chistyakov, Nadezhda Patkina, Anne Tammimäki, Reeta Talka, Outi Salminen, Irina Belozertseva, Timofey Galankin, Raimo Tuominen, Edwin Zvartau. Nicotine exposure throughout early development promotes nicotine self-administration in adolescent mice and induces long-lasting behavioural changes. European journal of pharmacology. 2010 Aug; 640(1-3):87-93. doi: 10.1016/j.ejphar.2010.04.044. [PMID: 20457149]
  • Tanuja Bordia, Carla Campos, J Michael McIntosh, Maryka Quik. Nicotinic receptor-mediated reduction in L-DOPA-induced dyskinesias may occur via desensitization. The Journal of pharmacology and experimental therapeutics. 2010 Jun; 333(3):929-38. doi: 10.1124/jpet.109.162396. [PMID: 20200117]
  • Richard W Fitch, Thomas F Spande, H Martin Garraffo, Herman J C Yeh, John W Daly. Phantasmidine: an epibatidine congener from the ecuadorian poison frog Epipedobates anthonyi. Journal of natural products. 2010 Mar; 73(3):331-7. doi: 10.1021/np900727e. [PMID: 20337496]
  • Takahiro Shimizu, Kunihiko Yokotani. Brain cyclooxygenase and prostanoid TP receptors are involved in centrally administered epibatidine-induced secretion of noradrenaline and adrenaline from the adrenal medulla in rats. European journal of pharmacology. 2009 Mar; 606(1-3):77-83. doi: 10.1016/j.ejphar.2009.01.032. [PMID: 19374850]
  • Alexandre Kuryatov, Jennifer Onksen, Jon Lindstrom. Roles of accessory subunits in alpha4beta2(*) nicotinic receptors. Molecular pharmacology. 2008 Jul; 74(1):132-43. doi: 10.1124/mol.108.046789. [PMID: 18381563]
  • Karen Riveles, Luping Z Huang, Maryka Quik. Cigarette smoke, nicotine and cotinine protect against 6-hydroxydopamine-induced toxicity in SH-SY5Y cells. Neurotoxicology. 2008 May; 29(3):421-7. doi: 10.1016/j.neuro.2008.02.001. [PMID: 18359086]
  • Alan L Pehrson, Scott D Philibin, Daniel Gross, Susan E Robinson, Robert E Vann, John A Rosecrans, John R James. The effects of acute and repeated nicotine doses on spontaneous activity in male and female Sprague Dawley rats: analysis of brain area epibatidine binding and cotinine levels. Pharmacology, biochemistry, and behavior. 2008 May; 89(3):424-31. doi: 10.1016/j.pbb.2008.01.018. [PMID: 18313740]
  • Lorise C Gahring, Amber V Osborne-Hereford, Gustavo A Vasquez-Opazo, Scott W Rogers. Tumor necrosis factor alpha enhances nicotinic receptor up-regulation via a p38MAPK-dependent pathway. The Journal of biological chemistry. 2008 Jan; 283(2):693-9. doi: 10.1074/jbc.m707330200. [PMID: 17977823]
  • Ruin Moaddel, Regina V Oliveira, Tomoko Kimura, Patrick Hyppolite, Magdalena Juhaszova, Yingxian Xiao, Kenneth J Kellar, Michel Bernier, Irving W Wainer. Initial synthesis and characterization of an alpha7 nicotinic receptor cellular membrane affinity chromatography column: effect of receptor subtype and cell type. Analytical chemistry. 2008 Jan; 80(1):48-54. doi: 10.1021/ac701943b. [PMID: 18062706]
  • Masahiro Ohtani, Takami Oka, Maryna Badyuk, Yingxian Xiao, Kenneth J Kellar, John W Daly. Mouse beta-TC6 insulinoma cells: high expression of functional alpha3beta4 nicotinic receptors mediating membrane potential, intracellular calcium, and insulin release. Molecular pharmacology. 2006 Mar; 69(3):899-907. doi: 10.1124/mol.105.014902. [PMID: 16332988]
  • Stephen T Lee, Kristin Wildeboer, Kip E Panter, William R Kem, Dale R Gardner, Russell J Molyneux, Cheng-Wei Tom Chang, Ferenc Soti, James A Pfister. Relative toxicities and neuromuscular nicotinic receptor agonistic potencies of anabasine enantiomers and anabaseine. Neurotoxicology and teratology. 2006 Mar; 28(2):220-8. doi: 10.1016/j.ntt.2005.12.010. [PMID: 16488116]
  • Loredana Riganti, Cosetta Matteoni, Silvia Di Angelantonio, Andrea Nistri, Annalisa Gaimarri, Fabio Sparatore, Caterina Canu-Boido, Francesco Clementi, Cecilia Gotti. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells. British journal of pharmacology. 2005 Dec; 146(8):1096-109. doi: 10.1038/sj.bjp.0706434. [PMID: 16273122]
  • Xin Hui, Jie Gao, Xin Xie, Naoki Suto, Tsuyoshi Ogiku, Ming-Wei Wang. A robust homogeneous binding assay for alpha4beta2 nicotinic acetylcholine receptor. Acta pharmacologica Sinica. 2005 Oct; 26(10):1175-80. doi: 10.1111/j.1745-7254.2005.00202.x. [PMID: 16174432]
  • Xiao-Qin Ren, Shi-Bin Cheng, Magdalen W Treuil, Jayanta Mukherjee, Jayaraman Rao, K H Braunewell, Jon M Lindstrom, Rene Anand. Structural determinants of alpha4beta2 nicotinic acetylcholine receptor trafficking. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2005 Jul; 25(28):6676-86. doi: 10.1523/jneurosci.1079-05.2005. [PMID: 16014729]
  • Marina Skok, Régis Grailhe, Jean-Pierre Changeux. Nicotinic receptors regulate B lymphocyte activation and immune response. European journal of pharmacology. 2005 Jul; 517(3):246-51. doi: 10.1016/j.ejphar.2005.05.011. [PMID: 15963492]
  • Richard A Pennington, Fan Gao, Steven M Sine, Richard J Prince. Structural basis for epibatidine selectivity at desensitized nicotinic receptors. Molecular pharmacology. 2005 Jan; 67(1):123-31. doi: 10.1124/mol.104.003665. [PMID: 15496507]
  • Yingxian Xiao, Kenneth J Kellar. The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells. The Journal of pharmacology and experimental therapeutics. 2004 Jul; 310(1):98-107. doi: 10.1124/jpet.104.066787. [PMID: 15016836]
  • Michael J Marks, Peter P Rowell, Jian-Zhe Cao, Sharon R Grady, Sarah E McCallum, Allan C Collins. Subsets of acetylcholine-stimulated 86Rb+ efflux and [125I]-epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment. Neuropharmacology. 2004 Jun; 46(8):1141-57. doi: 10.1016/j.neuropharm.2004.02.009. [PMID: 15111021]
  • Richard W Fitch, Xue-Feng Pei, Yumika Kaneko, Tara Gupta, Dan Shi, Irina Federova, John W Daly. Homoepiboxidines: further potent agonists for nicotinic receptors. Bioorganic & medicinal chemistry. 2004 Jan; 12(1):179-90. doi: 10.1016/j.bmc.2003.10.015. [PMID: 14697783]
  • A Lai, J Sum, H Fan, J M McIntosh, M Quik. Selective recovery of striatal 125I-alpha-conotoxinmii nicotinic receptors after nigrostriatal damage in monkeys. Neuroscience. 2004; 127(2):399-408. doi: 10.1016/j.neuroscience.2004.04.059. [PMID: 15262330]
  • Amy M Avila, Martha I Dávila-García, Veronica S Ascarrunz, YingxIan Xiao, Kenneth J Kellar. Differential regulation of nicotinic acetylcholine receptors in PC12 cells by nicotine and nerve growth factor. Molecular pharmacology. 2003 Oct; 64(4):974-86. doi: 10.1124/mol.64.4.974. [PMID: 14500754]
  • Steven Vernino, Vanda A Lennon. Neuronal ganglionic acetylcholine receptor autoimmunity. Annals of the New York Academy of Sciences. 2003 Sep; 998(?):211-4. doi: 10.1196/annals.1254.023. [PMID: 14592878]
  • Zhi-Zhong Guan, Wen-Feng Yu, Agneta Nordberg. Dual effects of nicotine on oxidative stress and neuroprotection in PC12 cells. Neurochemistry international. 2003 Aug; 43(3):243-9. doi: 10.1016/s0197-0186(03)00009-3. [PMID: 12689604]
  • Cynthia L Gentry, Lincoln H Wilkins, Ronald J Lukas. Effects of prolonged nicotinic ligand exposure on function of heterologously expressed, human alpha4beta2- and alpha4beta4-nicotinic acetylcholine receptors. The Journal of pharmacology and experimental therapeutics. 2003 Jan; 304(1):206-16. doi: 10.1124/jpet.102.041756. [PMID: 12490593]
  • Patricia C Harkness, Neil S Millar. Changes in conformation and subcellular distribution of alpha4beta2 nicotinic acetylcholine receptors revealed by chronic nicotine treatment and expression of subunit chimeras. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2002 Dec; 22(23):10172-81. doi: 10.1523/jneurosci.22-23-10172.2002. [PMID: 12451118]
  • Amynah A A Pradhan, Paul Cumming, Paul B S Clarke. [125I]Epibatidine-labelled nicotinic receptors in the extended striatum and cerebral cortex: lack of association with serotonergic afferents. Brain research. 2002 Nov; 954(2):227-36. doi: 10.1016/s0006-8993(02)03340-1. [PMID: 12414106]
  • Yi-Guo Long, Ya-Nan Wang, Jia Chen, Su-Fen Jiang, Agneta Nordberg, Zhi-Zhong Guan. Chronic fluoride toxicity decreases the number of nicotinic acetylcholine receptors in rat brain. Neurotoxicology and teratology. 2002 Nov; 24(6):751-7. doi: 10.1016/s0892-0362(02)00273-8. [PMID: 12460657]
  • Sandra Michelmore, Kim Croskery, Joachim Nozulak, Daniel Hoyer, Rémy Longato, Anja Weber, Rochdi Bouhelal, Dominik Feuerbach. Study of the calcium dynamics of the human alpha4beta2, alpha3beta4 and alpha1beta1gammadelta nicotinic acetylcholine receptors. Naunyn-Schmiedeberg's archives of pharmacology. 2002 Sep; 366(3):235-45. doi: 10.1007/s00210-002-0589-z. [PMID: 12172706]
  • David C Perry, Yingxian Xiao, Henry N Nguyen, John L Musachio, Martha I Dávila-García, Kenneth J Kellar. Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography. Journal of neurochemistry. 2002 Aug; 82(3):468-81. doi: 10.1046/j.1471-4159.2002.00951.x. [PMID: 12153472]
  • Z Z Guan, X Zhang, M Mousavi, J Y Tian, C Unger, A Nordberg. Reduced expression of neuronal nicotinic acetylcholine receptors during the early stages of damage by oxidative stress in PC12 cells. Journal of neuroscience research. 2001 Nov; 66(4):551-8. doi: 10.1002/jnr.1245. [PMID: 11746374]
  • E L Meyer, Y Xiao, K J Kellar. Agonist regulation of rat alpha 3 beta 4 nicotinic acetylcholine receptors stably expressed in human embryonic kidney 293 cells. Molecular pharmacology. 2001 Sep; 60(3):568-76. doi: NULL. [PMID: 11502889]
  • M Quik, Y Polonskaya, J M Kulak, J M McIntosh. Vulnerability of 125I-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2001 Aug; 21(15):5494-500. doi: 10.1523/jneurosci.21-15-05494.2001. [PMID: 11466420]
  • M A Javors, J J Sanchez, T S King, A R Rohde, S G Wilson, C M Flores. Extraction and quantification of epibatidine in plasma. Journal of chromatography. B, Biomedical sciences and applications. 2001 May; 755(1-2):379-82. doi: 10.1016/s0378-4347(01)00120-7. [PMID: 11393730]
  • C M Gaynor, S L Handley. Effects of nicotine on head-shakes and tryptophan metabolites. Psychopharmacology. 2001 Jan; 153(3):327-33. doi: 10.1007/s002130000558. [PMID: 11271405]
  • B Balestra, S Vailati, M Moretti, W Hanke, F Clementi, C Gotti. Chick optic lobe contains a developmentally regulated alpha2alpha5beta2 nicotinic receptor subtype. Molecular pharmacology. 2000 Aug; 58(2):300-11. doi: 10.1124/mol.58.2.300. [PMID: 10908297]
  • Z Guan, X Zhang, A Nordberg. Influence of lipid peroxidation on the nicotinic acetylcholine receptors in PC12 cells. Neuroscience letters. 2000 Jun; 286(3):163-6. doi: 10.1016/s0304-3940(00)01127-7. [PMID: 10832010]
  • Q Zheng, K Olivier, Y K Won, C N Pope. Comparative cholinergic neurotoxicity of oral chlorpyrifos exposures in preweanling and adult rats. Toxicological sciences : an official journal of the Society of Toxicology. 2000 May; 55(1):124-32. doi: 10.1093/toxsci/55.1.124. [PMID: 10788567]
  • J W Daly, H M Garraffo, T F Spande, M W Decker, J P Sullivan, M Williams. Alkaloids from frog skin: the discovery of epibatidine and the potential for developing novel non-opioid analgesics. Natural product reports. 2000 Apr; 17(2):131-5. doi: 10.1039/a900728h. [PMID: 10821107]
  • B Balestra, M Moretti, R Longhi, R Mantegazza, F Clementi, C Gotti. Antibodies against neuronal nicotinic receptor subtypes in neurological disorders. Journal of neuroimmunology. 2000 Jan; 102(1):89-97. doi: 10.1016/s0165-5728(99)00145-9. [PMID: 10626672]
  • R J Prince, S M Sine. Acetylcholine and epibatidine binding to muscle acetylcholine receptors distinguish between concerted and uncoupled models. The Journal of biological chemistry. 1999 Jul; 274(28):19623-9. doi: 10.1074/jbc.274.28.19623. [PMID: 10391899]
  • R D Mellon, B M Bayer. The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses. The Journal of pharmacology and experimental therapeutics. 1999 Feb; 288(2):635-42. doi: . [PMID: 9918569]
  • Y Xiao, E L Meyer, J M Thompson, A Surin, J Wroblewski, K J Kellar. Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function. Molecular pharmacology. 1998 Aug; 54(2):322-33. doi: 10.1124/mol.54.2.322. [PMID: 9687574]
  • E J Molinari, O Delbono, M L Messi, M Renganathan, S P Arneric, J P Sullivan, M Gopalakrishnan. Up-regulation of human alpha7 nicotinic receptors by chronic treatment with activator and antagonist ligands. European journal of pharmacology. 1998 Apr; 347(1):131-9. doi: 10.1016/s0014-2999(98)00084-3. [PMID: 9650859]
  • R J Prince, S M Sine. Epibatidine binds with unique site and state selectivity to muscle nicotinic acetylcholine receptors. The Journal of biological chemistry. 1998 Apr; 273(14):7843-9. doi: 10.1074/jbc.273.14.7843. [PMID: 9525877]
  • K A Stauderman, L S Mahaffy, M Akong, G Veliçelebi, L E Chavez-Noriega, J H Crona, E C Johnson, K J Elliott, A Gillespie, R T Reid, P Adams, M M Harpold, J Corey-Naeve. Characterization of human recombinant neuronal nicotinic acetylcholine receptor subunit combinations alpha2beta4, alpha3beta4 and alpha4beta4 stably expressed in HEK293 cells. The Journal of pharmacology and experimental therapeutics. 1998 Feb; 284(2):777-89. doi: NULL. [PMID: 9454827]
  • R L Papke, J S Thinschmidt, B A Moulton, E M Meyer, A Poirier. Activation and inhibition of rat neuronal nicotinic receptors by ABT-418. British journal of pharmacology. 1997 Feb; 120(3):429-38. doi: 10.1038/sj.bjp.0700930. [PMID: 9031746]
  • J W Daly. The chemistry of poisons in amphibian skin. Proceedings of the National Academy of Sciences of the United States of America. 1995 Jan; 92(1):9-13. doi: 10.1073/pnas.92.1.9. [PMID: 7816854]
  • B Badio, J W Daly. Epibatidine, a potent analgetic and nicotinic agonist. Molecular pharmacology. 1994 Apr; 45(4):563-9. doi: . [PMID: 8183234]